These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32697651)

  • 1. Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia.
    Ha AW; Sudhadevi T; Ebenezer DL; Fu P; Berdyshev EV; Ackerman SJ; Natarajan V; Harijith A
    Am J Physiol Lung Cell Mol Physiol; 2020 Sep; 319(3):L497-L512. PubMed ID: 32697651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia.
    Thomas JM; Sudhadevi T; Basa P; Ha AW; Natarajan V; Harijith A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins.
    Harijith A; Pendyala S; Reddy NM; Bai T; Usatyuk PV; Berdyshev E; Gorshkova I; Huang LS; Mohan V; Garzon S; Kanteti P; Reddy SP; Raj JU; Natarajan V
    Am J Pathol; 2013 Oct; 183(4):1169-1182. PubMed ID: 23933064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiling of genes regulated by sphingosine kinase1 signaling in a murine model of hyperoxia induced neonatal bronchopulmonary dysplasia.
    Natarajan V; Ha AW; Dong Y; Reddy NM; Ebenezer DL; Kanteti P; Reddy SP; Usha Raj J; Lei Z; Maienschein-Cline M; Arbieva Z; Harijith A
    BMC Genomics; 2017 Aug; 18(1):664. PubMed ID: 28851267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine kinase 1 regulates lysyl oxidase through STAT3 in hyperoxia-mediated neonatal lung injury.
    Ha AW; Bai T; Ebenezer DL; Sethi T; Sudhadevi T; Mangio LA; Garzon S; Pryhuber GS; Natarajan V; Harijith A
    Thorax; 2022 Jan; 77(1):47-57. PubMed ID: 33883249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts.
    Huang LS; Sudhadevi T; Fu P; Punathil-Kannan PK; Ebenezer DL; Ramchandran R; Putherickal V; Cheresh P; Zhou G; Ha AW; Harijith A; Kamp DW; Natarajan V
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase 1-specific inhibitor PF543 reduces goblet cell metaplasia of bronchial epithelium in an acute asthma model.
    Sudhadevi T; Ackerman SJ; Jafri A; Basa P; Ha AW; Natarajan V; Harijith A
    Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L377-L392. PubMed ID: 38290992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperoxia-induced S1P
    Sudhadevi T; Jafri A; Ha AW; Basa P; Thomas JM; Fu P; Wary K; Mehta D; Natarajan V; Harijith A
    Cell Biochem Biophys; 2021 Sep; 79(3):561-573. PubMed ID: 34176100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
    Hummler SC; Rong M; Chen S; Hehre D; Alapati D; Wu S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):578-88. PubMed ID: 23328640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1 Receptor Antagonist.
    Royce SG; Nold MF; Bui C; Donovan C; Lam M; Lamanna E; Rudloff I; Bourke JE; Nold-Petry CA
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):858-868. PubMed ID: 27482635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fingolimod, a sphingosine-1-phosphate receptor modulator, prevents neonatal bronchopulmonary dysplasia and subsequent airway remodeling in a murine model.
    Sudhadevi T; Annadi A; Basa P; Jafri A; Natarajan V; Harijith A
    J Appl Physiol (1985); 2024 Nov; 137(5):1231-1242. PubMed ID: 39262336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Sphingosine Kinase 1 Inhibitor, PF543, Mitigates Pulmonary Fibrosis by Reducing Lung Epithelial Cell mtDNA Damage and Recruitment of Fibrogenic Monocytes.
    Cheresh P; Kim SJ; Huang LS; Watanabe S; Joshi N; Williams KJN; Chi M; Lu Z; Harijith A; Yeldandi A; Lam AP; Gottardi C; Misharin AV; Budinger GRS; Natarajan V; Kamp DW
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium.
    Harijith A; Pendyala S; Ebenezer DL; Ha AW; Fu P; Wang YT; Ma K; Toth PT; Berdyshev EV; Kanteti P; Natarajan V
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L337-51. PubMed ID: 27343196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue growth factor antibody therapy attenuates hyperoxia-induced lung injury in neonatal rats.
    Alapati D; Rong M; Chen S; Hehre D; Rodriguez MM; Lipson KE; Wu S
    Am J Respir Cell Mol Biol; 2011 Dec; 45(6):1169-77. PubMed ID: 21659659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical roles of sphingosine kinase 1 in the regulation of neuroinflammation and neuronal injury after spinal cord injury.
    Wang C; Xu T; Lachance BB; Zhong X; Shen G; Xu T; Tang C; Jia X
    J Neuroinflammation; 2021 Feb; 18(1):50. PubMed ID: 33602274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.
    Vadivel A; Alphonse RS; Ionescu L; Machado DS; O'Reilly M; Eaton F; Haromy A; Michelakis ED; Thébaud B
    PLoS One; 2014; 9(3):e90965. PubMed ID: 24603989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1.
    Józefczuk E; Nosalski R; Saju B; Crespo E; Szczepaniak P; Guzik TJ; Siedlinski M
    Hypertension; 2020 Feb; 75(2):383-392. PubMed ID: 31838904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irisin alleviates hyperoxia-induced bronchopulmonary dysplasia through activation of Nrf2/HO-1 pathway.
    Zhao ZW; Lin XX; Guo YZ; He X; Zhang XT; Huang Y
    Peptides; 2023 Dec; 170():171109. PubMed ID: 37804931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS1 Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia in Mice by Activating Nrf2/HO-1 Mediated Ferroptosis.
    Yang M; Chen Y; Huang X; Shen F; Meng Y
    Lung; 2023 Aug; 201(4):425-441. PubMed ID: 37490064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants.
    Lal CV; Olave N; Travers C; Rezonzew G; Dolma K; Simpson A; Halloran B; Aghai Z; Das P; Sharma N; Xu X; Genschmer K; Russell D; Szul T; Yi N; Blalock JE; Gaggar A; Bhandari V; Ambalavanan N
    JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.